1 / 10

The Strategy for UK life sciences

The Strategy for UK life sciences. Building a life sciences ecosystem. £180m for the Biomedical Catalyst Fund. £130m for stratified medicines. £10m per annum in the Cell Therapy Catapult. EU VAT cost-sharing exemption in 2012 Finance Bill. VAT. Research Councils to jointly

fionan
Download Presentation

The Strategy for UK life sciences

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Strategy for UK life sciences

  2. Building a life sciences ecosystem £180m for the Biomedical Catalyst Fund £130m for stratified medicines £10m per annum in the Cell Therapy Catapult EU VAT cost-sharing exemption in 2012 Finance Bill VAT Research Councils to jointly invest £25m in Catapult research programme Make it easier to commercialise academic research

  3. Building a life sciences ecosystem (2) Investment in clinical research infrastructure Chris Brinsmead Life Sciences Champion Sir John Bell Life Sciences Champion Put clinical research at the heart of innovation in the NHS Independent life sciences champions Promote the UK as the place to invest and deliver life sciences innovation Encourage adoption and diffusion of innovation in the NHS Improved use of patient data in clinical research

  4. Attracting, developing and rewarding talent 420 High Level Apprenticeships over 5 years ● increase uptake of industry placements ● SME mentoring Programme ● Expansion of Society of Biology Accreditation Programme for undergraduate degrees

  5. Into the valley of death… Monitoring Clinical trials Licensing Preclinical research Basic research Phase 4 Phase 1 Phase 2 Phase 3 Private and institutional shareholders corporate venturing £ 2-10m Venture capital angels funding ‘valley of death’ research grants profit Phase 2 loss

  6. … but fear no ill Monitoring Clinical trials Licensing Preclinical research Basic research Phase 4 Phase 1 Phase 2 Phase 3 Private and institutional shareholders corporate venturing £ 180m Venture capital angels MRC/TSB Biomedical Catalyst Fund research grants profit Phase 2 loss

  7. Overcoming barriers Routes to market NICE Compliance Regime Revision of EU Clinical Trials Directive Regulatory audit and Red Tape Challenge

  8. Working within Whitehall Lord Howe Parliamentary Under Secretary of State for Quality Chris Brinsmead Life Sciences Champion David Willetts Minister for Universities and Science George Freeman Life Sciences adviser to David Willetts Economists & Analysts ED Information Hub Sir John Bell Life Sciences Champion

  9. Q & A Any questions?

More Related